A detailed history of Advisors Capital Management, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Advisors Capital Management, LLC holds 22,702 shares of CTLT stock, worth $1.37 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
22,702
Previous 76,949 70.5%
Holding current value
$1.37 Million
Previous $4.34 Million 70.6%
% of portfolio
0.02%
Previous 0.08%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$53.58 - $57.02 $2.91 Million - $3.09 Million
-54,247 Reduced 70.5%
22,702 $1.28 Million
Q1 2024

May 06, 2024

BUY
$42.56 - $59.82 $257,317 - $361,671
6,046 Added 8.53%
76,949 $4.34 Million
Q4 2023

Feb 14, 2024

BUY
$32.18 - $46.57 $574,123 - $830,855
17,841 Added 33.62%
70,903 $3.19 Million
Q3 2023

Nov 15, 2023

SELL
$44.2 - $50.2 $512,941 - $582,571
-11,605 Reduced 17.95%
53,062 $2.42 Million
Q2 2023

Aug 03, 2023

BUY
$31.86 - $67.26 $255,134 - $538,618
8,008 Added 14.13%
64,667 $2.8 Million
Q1 2023

May 04, 2023

SELL
$45.44 - $74.26 $427,953 - $699,380
-9,418 Reduced 14.25%
56,659 $3.72 Million
Q4 2022

Feb 13, 2023

SELL
$41.39 - $81.0 $87,208 - $170,667
-2,107 Reduced 3.09%
66,077 $2.97 Million
Q3 2022

Nov 16, 2022

BUY
$72.36 - $113.1 $1.68 Million - $2.63 Million
23,264 Added 51.79%
68,184 $3.19 Million
Q2 2022

Aug 12, 2022

BUY
$87.2 - $114.05 $88,769 - $116,102
1,018 Added 2.32%
44,920 $4.82 Million
Q1 2022

May 10, 2022

BUY
$94.19 - $124.49 $434,027 - $573,649
4,608 Added 11.73%
43,902 $4.87 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $828,380 - $963,476
6,928 Added 21.41%
39,294 $5.03 Million
Q3 2021

Nov 12, 2021

BUY
$109.17 - $142.35 $617,247 - $804,846
5,654 Added 21.17%
32,366 $4.31 Million
Q2 2021

Aug 02, 2021

BUY
$100.34 - $115.69 $542,538 - $625,535
5,407 Added 25.38%
26,712 $2.89 Million
Q1 2021

May 12, 2021

BUY
$101.51 - $125.27 $481,969 - $594,781
4,748 Added 28.68%
21,305 $2.24 Million
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $283,747 - $348,109
3,304 Added 24.93%
16,557 $1.72 Million
Q3 2020

Nov 05, 2020

BUY
$72.74 - $92.5 $74,776 - $95,090
1,028 Added 8.41%
13,253 $1.14 Million
Q2 2020

Aug 18, 2020

BUY
$48.02 - $79.04 $31,405 - $51,692
654 Added 5.65%
12,225 $896,000
Q1 2020

May 15, 2020

BUY
$36.95 - $62.95 $23,463 - $39,973
635 Added 5.81%
11,571 $601,000
Q4 2019

Jan 10, 2020

BUY
$47.06 - $56.64 $57,036 - $68,647
1,212 Added 12.46%
10,936 $616,000
Q3 2019

Nov 14, 2019

BUY
$47.45 - $58.05 $20,403 - $24,961
430 Added 4.63%
9,724 $463,000
Q2 2019

Aug 15, 2019

BUY
$39.26 - $54.21 $83,034 - $114,654
2,115 Added 29.46%
9,294 $504,000
Q1 2019

May 15, 2019

BUY
$29.84 - $43.92 $214,221 - $315,301
7,179 New
7,179 $292,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Advisors Capital Management, LLC Portfolio

Follow Advisors Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisors Capital Management, LLC with notifications on news.